Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
763.90-
QQQ
711.760.7%
BTC/USD
77808.810.9577%
DIA
529.600.37%
GLD
401.241.76%
TLT
81.760.54%

Cardio Diagnostics Holdings Inc

CDIONASDAQ
Trade with Public
Trade with Public
$1.87
0.021.08%
At close: Aug 28, 5:00 PM EST
$2.00
0.157.84%
Pre-Market: 4:09 AM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Cardio Diagnostics Hldgs Analyst Price Targets

Wall Street analyst price targets and consensus rating for Cardio Diagnostics Hldgs (CDIO).

Price Target Range — 2 Quarters

Analyst Consensus

Consensus RatingSpeculative BuyAvg. Consensus PT$2Upside to Avg. PT+0.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 27, 2024BenchmarkBruce JacksonMaintainedSpeculative Buy$2
Jun 6, 2024BenchmarkBruce JacksonPT RaiseSpeculative Buy$1→$2
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Benchmark Reiterates Speculative Buy on Cardio Diagnostics Hldgs, Maintains $2 Price Target

Benchmark analyst Bruce Jackson reiterates Cardio Diagnostics Hldgs (NASDAQ:CDIO) with a Speculative Buy and maintains $2 price target.
Benzinga Newsdesk

PRO
Benchmark Maintains Speculative Buy on Cardio Diagnostics Hldgs, Raises Price Target to $2

Benchmark analyst Bruce Jackson maintains Cardio Diagnostics Hldgs (NASDAQ:CDIO) with a Speculative Buy and raises the price target from $1.35 to $2.
Benzinga Newsdesk

PRO
Benchmark Maintains Speculative Buy on Cardio Diagnostics Hldgs, Lowers Price Target to $1.35

Benchmark analyst Bruce Jackson maintains Cardio Diagnostics Hldgs (NASDAQ:CDIO) with a Speculative Buy and lowers the price target from $4 to $1.35.
Benzinga Newsdesk

PRO
Benchmark Reiterates Speculative Buy on Cardio Diagnostics Hldgs, Maintains $8 Price Target

Benchmark analyst Bruce Jackson reiterates Cardio Diagnostics Hldgs (NASDAQ:CDIO) with a Speculative Buy and maintains $8 price target.
Benzinga Newsdesk

Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023

Benzinga Insights

PRO
Northland Capital Markets Initiates Coverage On Cardio Diagnostics Hldgs with Outperform Rating, Announces Price Target of $8

Northland Capital Markets analyst Carl Byrnes initiates coverage on Cardio Diagnostics Hldgs (NASDAQ:CDIO) with a Outperform rating and announces Price Target of $8.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved